+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Transdermal Drug Delivery - Technologies, Markets, and Companies

  • ID: 4748153
  • Report
  • 300 Pages
  • Jain PharmaBiotech
1 of 2

This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described.

Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease. The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2018 to 2028. This market is analyzed according to geographical regions as well.

Benefits of this report

  • Up-to-date one-stop information on transdermal drug delivery
  • Description of 100 companies involved and 105 collaborations in this area
  • Market analysis 2018-2028/
  • Market values in major regions
  • Strategies for developing markets for transdermal drug delivery
  • A selected bibliography of 200 publications
  • Text is supplemented by 22 tables and 18 figures

Who should read this report?

  • Biotechnology companies developing transdermal technologies
  • Drug delivery companies
  • Pharmaceutical companies interested in transdermal drug delivery
  • Pharmaceutical research institutes

The report contains information on the following:

  • Basics of Transdermal Drug Delivery
  • Transdermal Drug Delivery Technologies
  • Transdermal Therapeutics
  • Markets for Transdermal Drug Delivery
  • Companies involved in transdermal drug delivery
Note: Product cover images may vary from those shown
2 of 2

0. Executive Summary  

1. Basics of Transdermal Drug Delivery  
Historical landmarks in transdermal drug delivery  
Anatomy and physiology of skin  
Skin metabolomics and transcutaneous passage of drugs
Transcutaneous absorption
Transdermal versus other methods of drug delivery  
Advantages of transdermal drug delivery  
First-Pass Effect  
Drawbacks of transdermal delivery.
Factors that influence transdermal drug delivery  
Rate of permeation across the skin  
Properties of the skin
Properties of drugs
The role of pH and pharmacokinetics
Intradermal disposition of drugs after topical application  
Role of nanobiotechnology in understanding the basis of transdermal delivery  

2. Transdermal Drug Delivery Technologies
Local application formulations
Crystalline topical formulations  
Microemulsions for transdermal drug delivery  
Nanoemulsions for transdermal drug delivery  
Transdermal gel technology  
Biphasix system
Penetration enhancers
Chemical enhancers
Nitric oxide-based transdermal drug delivery  
Ionic liquids for transdermal delivery of drugs against bacterial biofilms on skin  
Vesicular transdermal carriers
Elastic vesicles for transdermal drug delivery
Nanovesicles for transdermal drug delivery  
Transdermal patches
Adhesives for transdermal patches
Commercial development of transdermal patches  
Innovations in transdermal patches  
e-Patch™ controlled release micropump system  
Patchless Transdermal Delivery System
Metered-dose transdermal system  
Polymers for transdermal drug delivery.
Polymer membranes in transdermal patches
Film forming polymeric solutions  
Crystal Reservoir System of Nitto Denko
Use of physical modalities to facilitate transdermal transport
Transdermal electrotransport  
Drug delivery by electroporation
Iontophoresis compared with electrophoresis
Application of iontophoresis for drug delivery
Patents in iontophoresis
Companies with technologies for drug delivery by iontophoresis
Combination of electrophoresis and iontophoresis  
Radiofrequency-driven transdermal delivery  
Transcutaneous drug delivery by electropulsation  
Companies involved in electroporation-based drug delivery
Electrode Scanning System
Use of electrostatic force in skin patch technology  
Multiple Absorption Kinetic System
Transdermal drug delivery facilitated by heat  
Controlled, heat-aided drug delivery  
Use of lasers for transdermal drug delivery
Laser-induced microporation  
Transdermal drug delivery by laser-induced pressure waves.
Transdermal drug delivery by laser-assisted changes in skin  
Transdermal delivery by gas under pressure
Transdermal delivery with PowderJect gas gun
Microneedle assisted microparticle delivery by a gene gun
Microscission induced by gas  
Role of microelectronics in transdermal drug delivery
Microneedles and dermal microinjection technologies
Applications of microneedles
AdminPatch® microneedle array  
Biodegradable microneedles  
Ceramic microneedle arrays  
Dissolvable microneedle patches  
Microneedle arrays for drug delivery
Microneedle patch  
MicroPyramid™ microneedles  
Microstructured Transdermal Systems  
Microneedle Array Patch technology
Microneedle transdermal chip  
Microneedle applicator device  
Nanoject™ microneedle technology  
Nanoneedle patch  
Polymer microneedles  
Silk microneedles
Tattooing for drug delivery  
ZP Patch microprojections technology
Companies developing microneedles for transdermal drug delivery  
Needlefree injections
Glide SDI® solid dose injector
Jet injection  
Mini-Ject needlefree delivery system  
MicroJet for painless injections  
Nanoliter-volume pulsed microjets
SUMAVEL™ DosePro™ needle-less injection  
Skin ablation or abrasion for drug delivery  
Nanotechnology-based transdermal drug delivery
Delivery of nanostructured drugs from transdermal patches  
Effect of mechanical flexion on penetration of bucky balls through the skin
Nanobiotechnology for transdermal application  
Nanoparticles and nanoemulsions for skin disorders  
Hyaluronic acid for facilitating transdermal passage of nanoconstructs
Ionic nanoparticle technology
SLN gel for treatment of skin disorders  
Topical delivery of siRNA- nanoparticle conjugates  
Transdermal nanoparticle preparations for systemic effect
Transdermal administration of nanocarriers  
Nanotechnology-based transdermal vaccination and immunotherapy  
Safety issues of applications of nanomaterial carriers on the skin
Comparison of transdermal drug delivery systems  
Transdermal drug design
In vitro testing of transdermal drug delivery systems
Commercially available skin models for transdermal drug testing  
FDA guidelines for post-approval changes in semisolid topical drugs.
In vivo testing of drug delivery systems  
Infrared spectroscopy for evaluation of transdermal drug delivery  
Modeling of transport through the skin
Concluding remarks on transdermal drug delivery technologies  
Future developments in transdermal drug delivery

3. Transdermal Therapeutics  
Drugs that can be administered transdermally  
Approved transdermal products
Drugs in clinical trials
Skin disorders  
Cutaneous leishmaniasis
Hair loss
Iontophoretic drug delivery for nail disorders
Nanoemulsions for paclitaxel delivery in psoriasis
Cardiovascular disorders
Transdermal estrogen for prevention of atherosclerotic cardiovascular disease  
Transdermal drug delivery for angina pectoris
Transdermal drug delivery for hypertension  
Transdermal clonidine
Transdermal delivery of β-blockers for hypertension  
Transdermal delivery of calcium channel blockers for hypertension
Transdermal drug delivery for congestive heart failure  
Transdermal beta blockers  
Transdermal anticoagulants  
Respiratory diseases  
Chronic obstructive pulmonary disease
Neurological and psychiatric disorders  
Parkinson's disease  
Transdermal drug delivery for Parkinson's disease  
Transdermal levodopa delivery systems
Transdermal dopamine agonists for Parkinson's disease
Rotigotine for Parkinson disease
Rotigotine for restless legs syndrome  
Transdermal administration of other drugs for Parkinson disease  
Selective serotonin-reuptake inhibitors  
Transdermal fluoxetine  
Monoamine oxidase inhibitors
Transdermal selegiline
Trazodone hydrochloride  
Bipolar disorder
Transdermal lithium  
Transdermal haloperidol  
Transdermal risperidone for treatment of schizophrenia
Transdermal blonanserin for treatment of schizophrenia  
Restless legs syndrome  
Alzheimer's disease  
Transdermal rivastigmine
Transdermal donepezil
Transdermal galantamine
Transdermal arecoline
Transdermal nicotine for Tourette syndrome
Attention deficit hyperactivity disorder  
Transdermal methylphenidate  
Transdermal sumatriptan
Transdermal zolmitriptan
Transdermal dihydroergotamine
Transdermal nitroglycerin for vasospasm due to subarachnoid hemorrhage
Musculoskeletal disorders  
Transdermal alendronate
Transdermal estrogen  
Transdermal human parathyroid hormone  
Transdermal therapy of diabetes
Insulin delivery in diabetes by transdermal patches  
Microneedle patch for glucose-responsive insulin delivery
Patch monitoring system for insulin delivery  
Sonic Applicator & Control Device for TDD of insulin
V-Go® disposable insulin delivery device  
ViaDor System for TDD of insulin
Companies developing devices for transdermal insulin delivery  
Transdermal therapy of oral antidiabetic agents
Male disorders
Erectile dysfunction  
Topical and transdermal preparation for erectile dysfunction  
Hypogonadism in the male  
Topical testosterone  
Benign prostatic hypertrophy.
Tamsulosin TDS  
Women's health
Female sexual arousal disorder  
Hormone replacement therapy for menopause  
Effect of transdermal estradiol on bone density
Transdermal PTH for postmenopausal osteoporosis
Transdermal testosterone for low libido in postmenopausal women
Breast disorders  
Female infertility  
Female contraception
Ortho Evra™  
Male contraception
Transdermal progestin plus testosterone  
Delivery of the photosensitizer drug δ-amino levulinic acid  
Intradermal delivery of cancer vaccines by adenoviral vectors
Nanoemulsion-based delivery of caffeine for skin cancer
Topical interferon α2b for cervical cancer and precancerous lesions  
Transcutaneous electroporation for delivery of anticancer drugs  
Transdermal delivery of peptide cancer vaccines  
Transdermal drug delivery for prostate cancer
Transdermal nitroglycerine for prostate cancer
Transdermal estradiol gel for prostate cancer
Transdermal leuprolide acetate for prostate cancer
Transdermal drug delivery for breast cancer  
Afimoxifene topical gel for breast cancer  
Relief of pain associated with minor medical procedures
Transdermal lidocaine relief of postherpectic neuralgia
Transdermal capsaicin for relief of pain
Nonsteroidal antiinflammatory drugs  
Topical NSAIDs
Transdermal ketoprofen
Topical opioids  
Cancer pain
Transdermal fentanyl.
Transdermal nitroglycerine as an adjuvant to opioids  
Transdermal buprenorphine
Chronic pain of non-malignant origin  
Transdermal local anesthetics  
Postoperative pain
Transdermal fentanyl for the management of postoperative pain  
Nanotechnology-based approved transdermal analgesic preparations
Nausea and vomiting
Motion sickness
Postoperative vomiting
Chemotherapy-induced nausea and vomiting  
Antiaging strategies  
Smoking cessation
Transdermal nicotine replacement  
Use of nicotine patch for smoking cessation in pregnancy
Other methods of nicotine replacement  
Other treatments for smoking cessation
Miscellaneous uses of transdermal drug delivery.
Allergic rhinitis.
Chronic fatigue syndrome
Delivery of cannabinoids
Overactive bladder and urinary incontinence
Transdermal oxybutynin  
Viral infections
Transdermal nanoparticles for immune enhancement in HIV.
Transdermal IQP-0410 for HIV/AIDS
Wound healing and ulcers
Transdermal gene therapy
Transdermal delivery of plasmid DNA by electroporation
Transdermal gene therapy for drug addiction  
Transdermal antisense therapy
Transdermal vaccination  
The skin as an immune organ  
Technologies for transdermal vaccination  
Dissolvable microneedle array for vaccine delivery  
Electroporation for administering DNA vaccines  
Microneedles for transdermal delivery of vaccines
Needle-free delivery of vaccines  
Transcutaneous immunotherapy using nanodispersions
Applications of transdermal vaccination  
HIV/AIDS vaccination by topical application  
Transdermal DNA influenza vaccine
Transdermal Aβ vaccination for Alzheimer’s disease  
Transdermal vaccination for traveller’s diarrhoea  
Epicutaneous desensitization for food allergy  
Peanut patch for peanut allergy  
Transdermal nutraceuticals
Complications of transdermal therapy
Adverse effects of drugs
Overdose effect
Skin complications
MRI-induced skin burns from transdermal patches  

4. Markets for Transdermal Drug Delivery  
Global markets for drug delivery
Geographical distribution of transdermal drug delivery markets
Emerging transdermal drug delivery markets in Asia  
Transdermal technology markets in therapeutic areas  
Angina pectoris  
Attention deficit hyperactivity disorder  
Erectile dysfunction  
Pain therapeutics
Parkinson's disease  
Smoking cessation
Transdermal hormone replacement therapy for menopause  
Transdermal testosterone replacement therapy for hypogonadism in the male  
Transdermal contraceptive market
Markets according to transdermal technologies.
Markets for microneedle-based transdermal drug delivery
Marketing strategies for transdermal drug delivery
Marketing advantages of transdermal drug delivery  
Unmet needs in transdermal drug delivery  
Regulatory aspects that affect transdermal drug delivery markets  
Future prospects of transdermal drug delivery  
Growth of new technologies used in transdermal drug delivery  
Prospects of transdermal delivery for drugs coming off patents  
Transdermal delivery of biologicals
Transdermal delivery of cosmetics

5. Companies involved in transdermal drug delivery  
Profiles of companies.
Top companies in transdermal drug delivery

6. References  


Table 1-1: Historical landmarks in the development of transdermal drug delivery  
Table 1-2: Transdermal vs oral and intravenous drug delivery
Table 1-3: Size ranges of molecules that can be delivered by transdermal route  
Table 2-1: Technologies for transdermal drug delivery
Table 2-2: Chemical enhancers of skin penetration  
Table 2-3: Drug-in-adhesive versus reservoir type of transdermal patch
Table 2-4: Companies with transdermal patches for drug delivery
Table 2-5: Companies with technologies for drug delivery by iontophoresis
Table 2-6: Companies involved in electroporation-based drug delivery
Table 2-7: Companies developing microneedles for transdermal drug delivery
Table 2-8: Comparison of transdermal drug delivery systems  
Table 3-1: Approved transdermal products
Table 3-2: Transdermal drugs in clinical trials or approval process
Table 3-3: Companies developing devices for transdermal insulin delivery  
Table 3-4: Selected transdermal systems GLP-1 antidiabetic agents
Table 4-1: Worldwide drug delivery market growth 2018 to 2028  
Table 4-2: Transdermal drug delivery markets for geographical regions 2018 to 2028  
Table 4-3: Markets for transdermal products for therapeutic areas 2018-2028  
Table 4-4: Markets according to transdermal technologies 2018-2028  
Table 4-5: Marketing strategies based on transdermal drug delivery technologies  
Table 5-1: Top five companies in transdermal drug delivery  
Table 5-2: Collaborations in transdermal drug delivery


Figure 1-1: Basic structure of the skin  
Figure 1-2: Passages of transcutaneous drug absorption  
Figure 1-3: Events governing transcutaneous drug absorption   
Figure 2-1: Basic structure and function of transdermal drug delivery systems  
Figure 2-2: Transdermal system for delivery of liquid drugs  
Figure 2-3: Crystal Reservoir System of Nitto Denko  
Figure 2-4: A schematic view of electroporation.
Figure 2-5: Depiction of breakdown of the stratum corneum during electroporation
Figure 2-6: A schematic drawing of Iontophoresis  
Figure 2-7: SonoPrep ultrasonic skin permeation
Figure 2-8: A a schematic sketch of PowderJect gas
Figure 2-9: Drug delivery using different types of microneedles (MN)
Figure 2-10: A schematic drawing of the microneedle patch  
Figure 2-11: Preparation of solid-in-oil nanodispersion for transdermal application
Figure 3-1: Oral versus transdermal administration of a drug in Parkinson's disease  
Figure 3-2: Control functions and user interface of insulin patch monitoring system
Figure 3-3: Transcutaneous immunotherapy using nanodispersions
Figure 3-4: Mechanism of action of epicutaneous immunotherapy  
Figure 4-1: Unmet needs in transdermal drug delivery

Note: Product cover images may vary from those shown
3 of 2